EXHIBIT 11. STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE
(Unaudited)
Eli Lilly and Company and Subsidiaries
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2006 | 2005 | 2006 | 2005 | |||||||||||||
| (Dollars and shares in millions except per-share data) | ||||||||||||||||
BASIC |
||||||||||||||||
Net income |
$ | 873.6 | $ | 794.4 | $ | 2,530.4 | $ | 1,279.0 | ||||||||
Average number of common shares outstanding |
1,085.2 | 1,088.6 | 1,085.0 | 1,087.6 | ||||||||||||
Contingently issuable shares |
.4 | .3 | .4 | .2 | ||||||||||||
Adjusted average shares |
1,085.6 | 1,088.9 | 1,085.4 | 1,087.8 | ||||||||||||
Basic earnings per share |
$ | .80 | $ | .73 | $ | 2.33 | $ | 1.18 | ||||||||
DILUTED |
||||||||||||||||
Net income |
$ | 873.6 | $ | 794.4 | $ | 2,530.4 | $ | 1,279.0 | ||||||||
Average number of common shares outstanding |
1,085.2 | 1,088.6 | 1,085.0 | 1,087.6 | ||||||||||||
Incremental shares — stock options and
contingently issuable shares |
1.2 | 2.8 | 1.4 | 3.5 | ||||||||||||
Adjusted average shares |
1,086.4 | 1,091.4 | 1,086.4 | 1,091.1 | ||||||||||||
Diluted earnings per share |
$ | .80 | $ | .73 | $ | 2.33 | $ | 1.17 | ||||||||